• / Free eNewsletters & Magazine
  • / My Account


Theravance THRX

Last Price$27.13Day Change (%)-0.22%
Open Price$27.33Day Change ($)-0.06
Day Range26.71–27.7952-Week Range26.04–42.96

As of Wed 04/16/2014 03:44 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Clinigen Group Acquires Oncology Support Therapy SAVENE® (dexrazoxane) from SpePharm AG

    Clinigen Group Acquires Oncology Support Therapy SAVENEĀ® (dexrazoxane) from SpePharm AG

  2. The Benefits of Diversifying the Funding of a Gold Position

    Theravance THRX reported second-quarter earnings that matched our expectations, and we are keeping our fair value estimate at $29 per share. The company continues to make progress in each of its programs, namely the addition of a second Phase IIb compound in the Beyond Advair trials and completion ...

Upcoming Events

©2014 Morningstar Advisor. All right reserved.